HCTI

The proposed acquisition of Roboticom would expand HCTI into industrial robotics and precision automation; Roboticom management's five-year forward-looking projections target $153.5 million in revenue and $64 million in adjusted operating contribution by fiscal year 2029/30; the projections were provided by Roboticom management, are unaudited and unverified by HCTI, subject to significant uncertainty, and actual results may differ materially PLEASANTON, Calif., Sept. 23, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company") today announced it has signed a non-binding Letter of Intent ("LOI") with Crestpoint Capital LLC ("Seller") outlining a proposed transaction in which HCTI would acquire certain intellectual property, trademarks and business assets associated with Roboticom (roboticom.it), a Pisa, Italy-based provider of industrial robotic automation systems for precision surface treatment, marketed under the SandRob™, ORTIS™ and ScultoRob™ product lines and serving aerospace, marine, composites, orthotics and prosthetics, and industrial-tooling customers.

HCTI to serve as U.S. technology and capital-markets partner, bringing AI, cloud and data expertise as ARCB and Kanzun launch cross-border healthcare investment platform PLEASANTON, Calif., Sept. 17, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a U.S.-based healthcare technology company, today announced that it has signed on as the U.S. technology and capital-markets partner for a new fund built to move Malaysian healthcare companies to the world stage.

Board of Directors Approves Stock Dividend Distribution of a Minority Interest of Outstanding Common Shares of Teyame AI Holdings Inc. Common Stock to Existing HCTI Shareholders; HCTI Signs Agreement in Connection with Planned Direct Listing of Teyame AI Holdings Inc. Transaction Subject to NASDAQ Approval PLEASANTON, Calif., Sept. 3, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a healthcare technology company delivering cloud, digital transformation, and data-driven solutions to healthcare and life sciences organizations, including AI-powered customer engagement services delivering AI-powered customer engagement and digital transformation services, today announced that it has signed a separation agreement (the "Separation Agreement") with its subsidiary Teyame AI Holdings Inc. ("Teyame AI Holdings") setting forth the terms governing the planned separation (the "Separation") of Teyame AI Holdings from HCTI.

AI-Powered Customer Engagement Segment Contributed $6.31 Million in Quarterly Revenue as Stockholders' Equity Climbed to $49.1 Million from $9.9 Million PLEASANTON, Calif., Aug. 13, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a technology company delivering AI-powered customer engagement and digital transformation services, is today reporting financial results for the second quarter ended June 30, 2026, which includes second quarter revenue of $9.19 million, up 158% year over year, with gross profit up 322% to $2.07 million.

Client Has Already Matched Its Full-Year 2025 Revenue by June 2026, with Annual Turnover Projected to Reach €2 Million PLEASANTON, Calif., Aug. 6, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations, today reported that its subsidiary, Teyame Holdings Inc. ("Teyame"), has released a progress report highlighting exceptional growth achieved on behalf of a key client — one of Spain's leading health insurance companies.

Transaction introduces 27 granted international patents, 61 pending applications , and a commercial pipeline targeting over US $50 million in cumulative revenue over three years. PLEASANTON, Calif.

Common shares outstanding increase to 14,644,322 following the closing of two previously approved transactions, providing added cushion under Nasdaq's newly effective Market Value of Listed Securities (MVLS) requirement PLEASANTON, Calif., July 29, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation, artificial intelligence, and cloud-infrastructure solutions for healthcare and life sciences organizations, today reported that, on July 24, 2026, it completed the issuance of an aggregate of 12,546,540 shares of common stock in connection with two previously shareholder-approved transactions: the closing of its acquisition involving Teyame AI LLC and related parties (the "Teyame Transaction"), and a Share Exchange Agreement with SecureKloud Technologies Ltd.

Names Veteran Health Tech & AI Services Leader Sumit Ganguli as Chairman & CEO to Fuel Multi-Year Recurring Revenue Growth Across a Multi-Billion-Dollar Healthcare AI Market PLEASANTON, Calif., July 27, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (NASDAQ: HCTI), a healthcare and life sciences technology company enabling digital transformation through cloud, data, artificial intelligence, and security solutions, today announced that proven industry executive Sumit Ganguli has been appointed Chairman and Chief Executive Officer of Purpose Health, Inc., HCTI's wholly owned, AI-led healthcare technology services subsidiary.

Recent Acquisitions powers the Revenue Growth and Gross Profit PLEASANTON, Calif., May 14, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today reported financial results for the first quarter ended March 31, 2026.

Positioning this new platform at the intersection of AI, healthcare delivery, and preventive wellness for Its Global Healthcare Expansion Strategy PLEASANTON, Calif., April 23, 2026 /PRNewswire/ -- Healthcare Triangle, Inc. (Nasdaq: HCTI) ("HCTI" or the "Company"), a leader in digital transformation solutions for healthcare and life sciences, today announced the launch of ZoraNex , an AI-driven digital self-care therapy platform developed under its wholly owned subsidiary, QuantumNexis Inc ("QuantumNexis").